New clinical, endoscopic, and imaging modalities for diagnosing varices and predicting bleeding are being investigated. Transnasal endoscopy and ultrathin battery-powered esophagoscopes are being used to improve patient comfort and compliance. Patients who respond to portal pressure-reducing drugs not only have a reduced risk of bleeding, but also a reduced risk of developing other complications, with improved survival. Nitrates have been shown to have no definite role in primary prophylaxis against variceal bleeding. The hemodynamic response to treatment has an independent prognostic value for the risk of variceal bleeding. Newer drugs have been investigated for reducing the hepatic venous pressure gradient, but with little success. Survival after bleeding has increased due to improved patient care and technological advances. Combined radiographic and endoscopic management of gastric varices is evolving and appears to be promising. Nonvariceal bleeding from portal hypertensive gastropathy is increasingly being recognized as a potential cause of bleeding in patients with portal hypertension, and pharmacotherapy with octreotide appears to be promising for the treatment of this condition. Variceal band ligation in children has been found to be as safe and effective as in adults.
References
-
1
Giannini E, Botta F, Borro P. et al .
Platelet count/spleen diameter ratio: proposal and validation of a noninvasive parameter to predict the presence of esophageal varices in patients with liver cirrhosis.
Gut.
2003;
52
1200-1205
-
2
Thomopoulos K C, Labropoulou-Karatza C, Mimidis K P. et al .
Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis.
Dig Liver Dis.
2003;
35
473-478
-
3
Saeian K, Staff D, Knox J. et al .
Unsedated transnasal endoscopy: a new technique for accurately detecting and grading esophageal varices in cirrhotic patients.
Am J Gastroenterol.
2002;
97
2246-2249
-
4
Madhotra R, Mokhashi M, Willner I. et al .
Prospective evaluation of a 3.1-mm battery-powered esophagoscope in screening for esophageal varices in cirrhotic patients.
Am J Gastroenterol.
2003;
98
807-812
-
5
Nakayama Y, Imuta M, Funama Y. et al .
CT portography by multidetector helical CT: comparison of three rendering models.
Radiat Med.
2002;
20
273-279
-
6
Matsuo M, Kanematsu M, Kim T. et al .
Esophageal varices: diagnosis with gadolinium-enhanced MR imaging of the liver for patients with chronic liver damage.
AJR Am J Roentgenol.
2003;
180
461-466
-
7
Sato T, Yamazaki K, Toyota J. et al .
Color Doppler findings of gastric varices compared with findings on computed tomography.
J Gastroenterol.
2002;
37
604-610
-
8
Pontes J M, Leitao M C, Portela F. et al .
Endosonographic Doppler-guided manometry of esophageal varices: experimental validation and clinical feasibility.
Endoscopy.
2002;
34
966-972
-
9
Miller L, Banson F L, Bazir K. et al .
Risk of esophageal variceal bleeding based on endoscopic ultrasound evaluation of the sum of esophageal variceal cross-sectional surface area.
Am J Gastroenterol.
2003;
98
454-459
-
10
Keiding S, Vilstrup H.
Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis.
Scand J Gastroenterol.
2002;
37
960-964
-
11
Choi Y J, Baik S K, Park D H. et al .
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.
J Gastroenterol Hepatol.
2003;
18
424-429
-
12
Abraldes J G, Tarantino I, Turnes J. et al .
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Hepatology.
2003;
37
902-908
-
13
Bureau C, Peron J M, Alric L. et al .
”A la carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding.
Hepatology.
2002;
36
1361-1366
-
14
Bellis L, Berzigotti A, Abraldes J G. et al .
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Hepatology.
2003;
37
378-384
-
15
Banares R, Moitinho E, Matilla A. et al .
Randomized comparison of long term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Hepatology.
2002;
36
1367-1373
-
16
Venon W D, Baronio M, Leone N. et al .
Effects of long-term irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study.
J Hepatol.
2003;
38
455-460
-
17
De B K, Bandyopadhyay K, Das T K. et al .
Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
Am J Gastroenterol.
2003;
98
1371-1376
-
18
Escorsell A, Gines A, Llach J. et al .
Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices.
Hepatology.
2002;
36
936-940
-
19
Garcia Pagan J C, Morillas R, Banares R. et al .
Propranolol plus placebo versus propranolol plus isosorbide mononitrate in the prevention of a first variceal bleed: a double blind RCT.
Hepatology.
2003;
37
1260-1266
-
20
Borroni G, Salerno F, Cazzaniga M. et al .
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
J Hepatol.
2002;
37
315-321
-
21
Abecasis R, Kravetz D, Fassio E. et al .
Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: a preliminary study.
Hepatology.
2003;
37
359-365
-
22
Spiegel B M, Targownik L, Dulai G S. et al .
Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective?.
Hepatology.
2003;
37
366-377
-
23
Arguedas M R, Heudebert G R, Eloubeidi M A. et al .
Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices.
Am J Gastroenterol.
2002;
97
2441-2452
-
24
D’Amico G, Pietrosi G, Tarantino I. et al .
Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.
Gastroenterology.
2003;
124
1277-1291
-
25
Yol S, Belviranli M, Toprak S. et al .
Endoscopic clipping versus band ligation in the management of bleeding esophageal varices.
Surg Endosc.
2003;
17
38-42
-
26
D’Amico G, De Franchis R and a Cooperative study group.
Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators.
Hepatology.
2003;
38
599-612
-
27
Chalasani N, Kahi C, François F. et al .
Improved patient survival after acute variceal bleeding: a multicenter cohort study.
Am J Gastroenterol.
2003;
98
653-659
-
28
Evrard S, Dumonceau J M, Delhaye M. et al .
Endoscopic Histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial.
Endoscopy.
2003;
35
729-735
-
29
Merli M, Nicolini G, Angeloni S. et al .
Incidence and natural history of small esophageal varices in cirrhotic patients.
J Hepatol.
2003;
38
266-272
-
30
Taniai N, Onda M, Tajiri T. et al .
Combined endoscopic and radiologic intervention to treat esophageal varices.
Hepatogastroenterology.
2002;
49
984-988
-
31
Tajiri T, Onda M, Yoshida H. et al .
The natural history of gastric varices.
Hepatogastroenterology.
2002;
49
1180-1182
-
32
Arakawa M, Masuzaki T, Okuda K.
Pathology of fundic varices of the stomach and rupture.
J Gastroenterol Hepatol.
2002;
17
1064-1069
-
33
Wu C Y, Yeh H Z, Chen G H.
Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis.
J Clin Gastroenterol.
2002;
35
127-132
-
34
Battaglia G, Bocus P, Morbin T. et al .
Endoscopic Doppler US-guided injection for gastric varices: case report.
Gastrointest Endosc.
2003;
57
608-611
-
35
Yang W L, Tripathi D, Therapondos G. et al .
Endoscopic use of human thrombin in bleeding gastric varices.
Am J Gastroenterol.
2002;
97
1381-1385
-
36
Shiba M, Higuchi K, Nakamura K. et al .
Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: a prospective, randomized, comparative clinical trial.
Gastrointest Endosc.
2002;
56
522-528
-
37
Miyamoto Y, Oho K, Kumamoto M. et al .
Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
J Gastroenterol Hepatol.
2003;
18
934-942
-
38
Tripathi D, Therapondos G, Jackson E. et al .
The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations.
Gut.
2002;
51
270-274
-
39
Chu E C, Chick W, Hillebrand D J. et al .
Fatal spontaneous gallbladder variceal bleeding in a patient with alcoholic cirrhosis.
Dig Dis Sci.
2002;
47
2682-2685
-
40
Handschin A E, Weber M, Weishaupt D. et al .
Contrast-enhanced three-dimensional magnetic resonance angiography for visualization of ectopic varices.
Dis Colon Rectum.
2002;
45
1541-1544
-
41
Yoo H Y, Eustace J A, Verma S. et al .
Accuracy and reliability of the endoscopic classification of portal hypertensive gastropathy.
Gastrointest Endoscopy.
2002;
56
675-680
-
42
Zhou Y, Qiao L, Wu J. et al .
Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study.
J Gastroenterol Hepatol.
2002;
17
973-979
-
43
Bruha R, Marecek Z, Spicak J. et al .
Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding.
Hepatogastroenterology.
2002;
49
1161-1166
-
44
Shimizu T, Onda M, Tajiri T. et al .
Bleeding portal-hypertensive gastropathy managed successfully by partial splenic embolization.
Hepatogastroenterology.
2002;
49
947-949
-
45
Saftoiu A, Ciurea T.
Aphagia caused by accidental banding of the esophageal circumference.
Endoscopy.
2002;
34
1030-1031
-
46
Lorenz A, Stadtler N, Schulz H J.
Laser disintegration of cyanoacrylate clot with successful endoscopic removal of sclerotherapy needle from gastric varix.
Endoscopy.
2002;
34
670-672
-
47
Reynaert H.
Nadolol-induced painful gingival bleeding.
J Hepatol.
2002;
37
289
-
48
Zargar S A, Javid G, Khan B A. et al .
Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction.
Hepatology.
2002;
36
666-672
-
49
Dowidar N, Hafez A.
Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis: a randomized controlled trial evaluating effect of sclerosant concentration.
J Egypt Soc Parasitol.
2002;
32
537-549
-
50
Avgerinos A, Viazis N, Armonis A. et al .
Early increase of lower oesophageal sphincter pressure after band ligation of oesophageal varices in cirrhotics: an intriguing phenomenon.
Eur J Gastroenterol Hepatol.
2002;
14
1319-1323
D. K. Bhasin, M. D., D. M.
Dept. of Gastroenterology, Postgraduate Institute of Medical Education and Research
1041, Sector 24-B · Chandigarh-160 023 · India
Fax: +91-172-2744401 ·
eMail: dkbhasin@sancharnet.in
